05-23425. Breast and Cervical Cancer Early Detection and Control Advisory Committee  

  • Start Preamble

    In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting:

    Name: Breast and Cervical Cancer Early Detection and Control Advisory Committee (BCCEDCAC).

    Times and Dates: 8:30 a.m.-5 p.m., December 6, 2005. 8:30 a.m.-1 p.m., December 7, 2005.

    Place: Embassy Suites Hotel, Centennial Olympic Park, 267 Marietta Street, Atlanta, Georgia 30313.

    Phone: 1-404-223-2300.

    Status: Open to the public, limited only by the space available.

    Purpose: The committee is charged with advising the Secretary, Department of Health and Human Services, and the Director, CDC, regarding the early detection and control of breast and cervical cancer. The committee makes recommendations regarding national program goals and objectives; implementation strategies; and program priorities including surveillance, epidemiologic investigations, education and training, information dissemination, professional interactions and collaborations, and policy.

    Matters to be Discussed: The agenda will include discussion and review of the vision for National Cancer Prevention and Control Program; strategies for Performance-Based Funding; Case Management; update of expert panel meetings; HPV Testing and the Breast and Cervical Program; and HPV Vaccine update.

    Agenda items are subject to change as priorities dictate.

    Contact Person for More Information: Debra Younginer, Executive Secretary, BCCEDCAC, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, Mailstop K-57, Chamblee, Georgia 30316, Telephone: 770-488-1074.

    The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry.

    Start Signature

    Alvin Hall,

    Director, Management Analysis and Services Office, Centers for Disease Control.

    End Signature End Preamble

    [FR Doc. 05-23425 Filed 11-28-05; 8:45 am]

    BILLING CODE 4163-18-P

Document Information

Comments Received:
0 Comments
Published:
11/29/2005
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Document Number:
05-23425
Dates:
8:30 a.m.-5 p.m., December 6, 2005. 8:30 a.m.-1 p.m., December 7, 2005.
Pages:
71538-71538 (1 pages)
PDF File:
05-23425.pdf